Ophthalmology · Wilmington, NC
NPI
1205881612
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1025 Medical Center Dr Ste 201
Wilmington, NC, 28401
Phone (910) 444-0707
Groups this clinician bills Medicare through
Medicare paid, 2024
$415K
8,379 services
Medicare patients, 2024
749
Average age 75
Drug cost, 2024
$232K
1,731 prescriptions
Company payments, 2025
$527
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George K Escaravage Jr. was code J0585 (injection, onabotulinumtoxina, 1 unit), 6,029 times for 39 patients. In total George K Escaravage Jr. billed 8,379 services in 81 codes, and Medicare paid $415K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 6,029 | 39 | $4.87 | $29K |
| 92285 Standard X-ray | Office | 358 | 356 | $15.64 | $5,598 |
| 99204 Office E&M - New | Office | 246 | 246 | $101.86 | $25K |
| 15823 Skin | Facility | 206 | 206 | $598.18 | $123K |
| 92081 Vision, Hearing, and Speech Services | Office | 170 | 170 | $19.67 | $3,343 |
| 99214 Office E&M - Established | Office | 156 | 145 | $90.70 | $14K |
| 99213 Office E&M - Established | Office | 149 | 117 | $58.65 | $8,739 |
| 64612 Musculoskeletal | Office | 123 | 39 | $114.43 | $14K |
| 67904 Eye | Facility | 95 | 95 | $636.67 | $60K |
| 99203 Office E&M - New | Office | 39 | 39 | $54.00 | $2,106 |
| 68810 Eye | Office | 37 | 35 | $137.95 | $5,104 |
| 67900 Eye | Facility | 32 | 32 | $360.41 | $12K |
| 14060 Skin Grafting | Facility | 31 | 31 | $455.71 | $14K |
| 67850 Eye | Facility | 23 | 23 | $57.13 | $1,314 |
| 99212 Office E&M - Established | Office | 23 | 22 | $28.65 | $659 |
By year: 2022 $464K for 9,397 services; 2023 $391K for 8,424 services; 2024 $415K for 8,379 services.
Medicare prescription drug claims, 2024
In 2024, the drug George K Escaravage Jr. prescribed most often to Medicare patients was Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha), with 1,018 prescriptions and refills. In total George K Escaravage Jr. wrote 1,731 Medicare prescriptions that cost $232K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 1,018 | 1,032 | 667 | $12K |
| Tramadol Hcl Generic | 388 | 388 | 383 | $498 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 90 | 90 | 89 | $264 |
| Erythromycin Erythromycin Base | 49 | 49 | 34 | $540 |
| Doxycycline Hyclate Generic | 29 | 30 | 22 | $1,241 |
| Alprazolam Generic | 18 | 21 | Under 11 | $179 |
| Moxifloxacin Moxifloxacin Hcl | 17 | 19 | 13 | $282 |
| Cephalexin Generic | 11 | 11 | 11 | $43.08 |
| Methylprednisolone Generic | 11 | 11 | Under 11 | $116 |
Brand drugs: 551 claims; generic drugs: 1,180 claims; opioid claims: 482.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George K Escaravage Jr. $527 ($527 in general payments such as food, travel and fees) from 4 companies. The largest payer was Amgen Inc. with $313.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.